Medimetriks Pharmaceuticals, Inc. is led by the key Senior Management Team of the former Bradley Pharmaceuticals, Inc.  The company’s mission is to develop, license and commercialize innovative prescription skincare brands that fill unmet needs in the Dermatology and Podiatry markets.  Medimetriks’ therapies treat conditions including acne, rosacea, seborrheic dermatitis, severe dry skin, dystrophic nails and impetigo.